GENERAL
Pharma Sector Revenue Growth Seen At 11-13% This Fiscal: Crisil Ratings
India’s pharmaceutical sector is expected to see revenue growth accelerate to 11-13% this fiscal from 8% last fiscal, supported by stronger exports and firmer domestic demand, according to Crisil Ratings. However, the improvement in revenue is unlikely to translate fully into earnings as higher raw material, energy and freight costs are expected to put pressure […]
CW Bureau
·
Sep 24, 2026
GENERAL
Aurobindo Eyes $494-Mn US Market With Launch Of Tofacitinib Generic
Aurobindo Pharma has strengthened its presence in the lucrative US generics market after receiving final approval from the US Food and Drug Administration (USFDA) for Tofacitinib tablets in 5 mg and 10 mg strengths, opening the door to a market worth nearly $500 million annually. The approval allows the company to manufacture and market a […]
CW Bureau
·
Jun 4, 2026
GENERAL
Tiger Logistics Sees Bright Future In Coming Quarters As Solar Shines
Amid persistent global trade disruptions, ranging from U.S. tariff uncertainties to geopolitical tensions and demand weakness in key overseas markets, Tiger Logistics (India) Ltd has reported resilient volume growth, even as historically low freight rates weighed on revenue during the quarter. “The overall business is getting settled. With U.S. tariff issues showing signs of resolution […]
CW Bureau
·
Feb 25, 2026
